Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 19 | $909,016 |
Sells | 1 | $1,834 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Dec 2023 18:21 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 14 Dec 2023 | Purchase | 22,627 | 1.04 | 23,532 | I |
14 Dec 2023 18:21 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 13 Dec 2023 | Purchase | 22,627 | 1 | 22,627 | I |
14 Dec 2023 18:21 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 12 Dec 2023 | Purchase | 22,327 | 1.02 | 22,774 | D |
14 Dec 2023 18:21 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 12 Dec 2023 | Purchase | 300 | 1 | 300 | I |
07 Dec 2023 18:30 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 06 Dec 2023 | Purchase | 19,123 | 1.02 | 19,505 | I |
07 Dec 2023 18:30 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 07 Dec 2023 | Purchase | 19,123 | 1.01 | 19,314 | I |
07 Dec 2023 18:30 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 05 Dec 2023 | Purchase | 19,123 | 1.01 | 19,314 | I |
01 Dec 2023 13:38 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 01 Dec 2023 | Purchase | 14,378 | 0.94 | 13,515 | I |
01 Dec 2023 13:38 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 30 Nov 2023 | Purchase | 14,378 | 0.9 | 12,940 | I |
01 Dec 2023 13:38 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 29 Nov 2023 | Purchase | 14,378 | 0.98 | 14,090 | I |
31 Aug 2023 18:42 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 31 Aug 2023 | Purchase | 41,026 | 1.32 | 54,154 | I |
31 Aug 2023 18:42 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 30 Aug 2023 | Purchase | 41,026 | 1.31 | 53,744 | I |
17 Aug 2023 18:08 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 17 Aug 2023 | Purchase | 24,766 | 1.29 | 31,948 | I |
17 Aug 2023 18:08 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 16 Aug 2023 | Purchase | 117,348 | 1.29 | 151,379 | I |
17 Aug 2023 18:08 | QNCX | Quince Therapeutics Inc | LAMOND DAVID | Director | 15 Aug 2023 | Purchase | 107,886 | 1.32 | 142,410 | I |
11 Aug 2023 16:15 | QNCX | Quince Therapeutics Inc | THYE DIRK | Chief Executive Officer | 10 Aug 2023 | Purchase | 88,000 | 1.26 | 110,880 | D |
09 Aug 2023 18:23 | QNCX | Quince Therapeutics Inc | THYE DIRK | Chief Executive Officer | 08 Aug 2023 | Purchase | 80,000 | 1.24 | 99,200 | D |
09 Aug 2023 18:21 | QNCX | Quince Therapeutics Inc | HANNAH BRENDAN | Chief Business Officer | 08 Aug 2023 | Purchase | 71,762 | 1.22 | 87,550 | D |
09 Aug 2023 18:18 | QNCX | Quince Therapeutics Inc | MCLOUGHLIN MARGARET | Director | 08 Aug 2023 | Purchase | 8,000 | 1.23 | 9,840 | D |
06 Mar 2023 18:55 | QNCX | Quince Therapeutics Inc | MONOHON TED | Chief Accounting Officer & VP | 06 Mar 2023 | Sale | 1,871 | 0.98 | 1,834 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)